Clinical Trials

20 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07498725 2026-03-27

A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors

120 enrolled

Tumor-Agnostic

Neoplasms

NCT07477444 2026-03-20

HER-OIC

29 enrolled

Gastroesophageal Cancer

NCT03424005 2026-03-16

Morpheus-panBC

792 enrolled

Breast Neoplasms

NCT07472647 2026-03-16

SYS6090 Combination Therapy in Advanced Lung Cancer

596 enrolled

Phase 1/2 Active not recruiting

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT04262466 2026-03-06

Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors

410 enrolled

Other solid neoplasm

Select Advanced Solid Tumors

NCT05214482 2026-03-03

A Study of AK112 in Advanced Malignant Tumors

Phase 1/2 Active not recruiting

154 enrolled

Advanced Malignant Tumors

NCT04868877 2026-02-19

Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination

194 enrolled

GastrointestinalHead & Neck

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Head and Neck Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT05731947 2026-01-29

Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors

42 enrolled

Colorectal Neoplasms

NCT02961101 2026-01-22

Anti-PD-1 Antibody Alone or in Combination With Decitabine/Chemotherapy in Relapsed or Refractory Malignancies

250 enrolled

Neoplasms, Recurrence

NCT07342725 2026-01-15

Phase Ib/II Study to Evaluate the Safety and Efficacy of IBI363 in Combination With Chemotherapy as Second-Line Therapy for Unresectable Locally Advanced or Metastatic Pancreatic Cancer

48 enrolled

Pancreatic Cancer Metastatic

NCT06596018 2025-12-30

Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy

96 enrolled

Breast Neoplasms

NCT02806258 2025-12-29

Néo-APBI-01

Phase 1/2 Terminated

362 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06529809 2025-12-24

Accelerated Brachytherapy Forward Chemo Radiation Therapy (ABC-RT) for Locally-advanced Cervical Cancer

50 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT07291947 2025-12-18

PULSAR Combined With Immunotherapy and Chemotherapy

60 enrolled

Cholangiocarcinoma

NCT07261592 2025-12-03

Entinostat & Chemotherapy for Locally Advanced or Metastatic Bladder Cancer

29 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT06228326 2025-10-24

KYANITE-1

250 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT06090864 2025-10-20

ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells

Phase 1/2 Active not recruiting

31 enrolled

Lymphoid

Hodgkin Disease, Recurrence

NCT04888312 2025-10-08

OPTIMIZE-1

94 enrolled

Pancreatic Neoplasms

NCT07190027 2025-09-24

Immunodynamics-Guided Optimization of Individualized Immunochemotherapy in Advanced Driver-Negative NSCLC: A Randomized Trial

246 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07161791 2025-09-09

Camrelizumab, Pirfenidone, and Chemotherapy in the Treatment of Advanced Triple-Negative Breast Cancer

12 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07131345 2025-08-20

Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma

Other solid neoplasmThoracic

55 enrolled

Mesothelioma, Malignant, Mesothelioma

NCT06758544 2025-08-17

A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic Cancer

18 enrolled

Pancreatic Neoplasms

NCT02327078 2025-08-14

A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)

CNSDermatologicGastrointestinalGynecologicHead & NeckLymphoidThoracic

307 enrolled 27 charts

Glioblastoma, Head and Neck Neoplasms, Lung Neoplasms, Lymphoma, Melanoma, Ovarian Neoplasms, Colorectal Neoplasms

NCT06602063 2025-06-27

Surgery for Relapsed Ovarian Cancer in Precision

33 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06943820 2025-06-03

AK129 Combination Therapy for Advanced Solid Tumors

230 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT06941766 2025-04-30

Iparomlimab and Tuvonralimab (QL1706) for Intermediate Trophoblastic Tumors

20 enrolled

Intermediate Trophoblastic Tumor

NCT02649829 2025-04-29

MESODEC